Which hedge funds own TBPH? THERAVANCE BIOPHARMA INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
7 of the hedge funds tracked by WhaleCreep disclosed a position in TBPH (THERAVANCE BIOPHARMA INC) in their Q2 2026 13F filings, worth $84.5m in total. The largest holder by portfolio weight is Irenic Capital Management at 3.4% of its book. 1 manager opened a new position this quarter: Millennium Management. 1 exited: Woodline Partners.
7tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold TBPH? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Irenic Capital Management | Q2 2026 | 3.4% | $46.9m | 2,760,948 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $20.2m | 1,185,390 | 24% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $8.6m | 506,668 | 489% | added |
| Tudor Investment | Q2 2026 | 0.0% | $1.0m | 60,425 | -50% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $2.6m | 154,318 | 21% | added |
| Marshall Wace | Q2 2026 | 0.0% | $3.2m | 188,748 | 19% | added |
| Millennium Management | Q2 2026 | 0.0% | $2.0m | 115,403 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Woodline Partners | 0.0% | $488.9k |
How has hedge fund ownership of TBPH changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $84.5m |
| Q1 2026 | 7 | $68.8m |
| Q4 2025 | 2 | $55.2m |
| Q3 2025 | 2 | $41.1m |
| Q2 2025 | 3 | $32.8m |
| Q1 2025 | 2 | $26.4m |
| Q4 2024 | 2 | $27.8m |
| Q3 2024 | 2 | $23.8m |
| Q2 2024 | 3 | $60.7m |
| Q1 2024 | 4 | $85.5m |
| Q4 2023 | 4 | $114.5m |
| Q3 2023 | 4 | $88.8m |
| Q2 2023 | 4 | $106.6m |
| Q1 2023 | 4 | $144.2m |
| Q4 2022 | 5 | $150.2m |
| Q3 2022 | 5 | $142.4m |
Counts every tracked manager that disclosed TBPH in that quarter's filing, including managers that have since stopped filing.